Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation

Annals of Nutrition and Metabolism

Volumn 41, Issue 6, 1997, Pages 353-357

  Day, A P ^a   Kemp, H J ^a   Bolton, C ^a   Hartog, M ^a   Stansbie, D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Elderly; Infectious diseases; Vitamin B6; Vitamin C

Indexed keywords

ANTIOXIDANT; LOW DENSITY LIPOPROTEIN;

ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; FRUIT JUICE; GRAPE; HUMAN; HUMAN EXPERIMENT; LIPID OXIDATION; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL; WINE;

VITIS SP.;

EID: 0030662590     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000178006     Document Type: Article

References (20)

1. Renaud S. DeLorgeril M: Wine, alcohol. platelets, and the French paradox for coronary heart disease. Lancet 1992;339:1523-1526.
2. Gronbsk M. Deis A, Sorensen TIA. Becker U. Schnohr P, Jensen G: Mortality associated with moderate intakes of wine, beer, or spirits. BMJ 1995:310:1165-1169.
3. Goldberg DM: Does wine work? (editorial) Clin Chem 1995:41:14-16.
4. Leake D: The French paradox (review). Biochemist 1995:Feb/Mar: 12-15.
5. Hertog MGL, Hollman PCH, van de Putte B: Content of potentially anticarcinogenic flavonoids of tea infusions, wine, and fruit juices. J Agric Food Chem 1993:41:1242-1246.
6. Maxwell S, Cruickshank A, Thorpe G,: Red wine and antioxidant activity in serum (letter). Lancet 1994; 344:193-194.
7. Whitehead TP, Robinson D, Allaway S, Svms J, Hale A,: Effect of red wine ingestion on the antioxidant capacity of serum. Clin Chem 1995; 41:32-35.
8. Frankel EN, Kanner J, German JB. Parks E. Kinsella JE: Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993:341:454-457.
9. Scuckit MA: Alcohol and alcoholism; in Braunwald E. Isselbacher KJ. Petersdorf RG. Wilson JD. Martin MB. Fauci AS (eds): Harrison’s Principles of Internal Medicine. ed 11. New York. McGraw-Hill, 1987. Pp 2106-2111.
10. Whitehead TP. Thorpe GHG. Maxwell SRJ: Enhanced chemiluminescent assay for antioxidant capacity in biological fluids. Anal Chim Acta 1992;266:265-277.
11. Kleinveld HA, Hak-Lemmers HIM, Stalenhoef AFH, Demacker PNM,: Improved measurement of low-den-sity-lipoprotein susceptibility to copper-induced oxidation: Application of a short procedure for isolating low-density lipoprotein. Clin Chem 1992;38:2066-2072.
12. Steer KA, Wallace TM, Bolton CH, Hartog M,: Aspirin protects low density lipoprotein from oxidative modification. Heart 1997; in press.
13. Young IS, Trimble ER,: Measurement of malondialdehydc in plasma by high performance liquid chromatography with lluorimetric detection. Ann Clin Biochem 1991:28: 504-508.
14. Hertog MGL, Hollman PCH, Vcnc-ma DP: Optimisation of a quantitative HPLC determination of potentially anticarcinogenic flavonoids in vegetables and fruits. J Agric Food Chem 1992:40:1591-1598.
15. Day AP, Stansbie D: Cardioprotective effect of red wine may be mediated by urate (letter). Clin Chem 1995:41:1319-1320.
16. Hertog MGL, Hollman PCH, Katan MB. Krumhold D: Estimation of daily intake of potentially anticarcinogenic flavonoids and their determinants in The Netherlands. Nutr Cancer 1993;20:21-29.
17. Knekt P. Jarvinen R. Reunanen A. Maatela J: Flavonoid intake and coronary mortality in Finland: A cohort study. BMJ 1996:312:478-481.
18. Eisterbauer H, Striegl G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun 1989:6:67-75.
19. Kondo K. Matsumoto A. Kurata H, Tanahashi H. Koda H, Amachi T, Itakura H: Inhibition of oxidation of low-density lipoprotein with red wine (letter). Lancet 1994,344: 1152.
20. Sharpe PC. McGrath LM. McClean E, Young IS, Archibold GPR: Effect of red wine consumpt ion on lipoprotein (a) and other risk factors for atherosclerosis. Q J Med 1995:88:101-108.